Lactoferrin Alone ,Iron Alone Vs Lactoferrin Plus Iron for Treatment of Iron Deficiency Anemia
Key facts
- Who runs it
- Egymedicalpedia
- Where
- Egypt1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 399 people enrolled
- Started
- 10 Jun 2023
- Ended
- 10 Jun 2024
- Type of study
- Interventional, 3 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Lactoferrin
- Record updated
- 19 September 2024
Who can take part
- Age
- 20 years to 35 years
- Sex
- Women only
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 9 criteriaShow less
Who can take part
- Pregnant women with single fetus
- All pregnant women in 3rd trimester (28w_36w) complaining of mild IDA
- Iron Deficiency Anemia mild anemia (hemoglobin level < 11 mg/dl , and serum ferritin level < 12 mg/dl)
Who cannot take part
- Patients with a history of anemia due to any other causes such as chronic blood loss, hemolytic anemia, and thalassemia
- History of peptic disorders
- Malabsorption syndrome
- Clinical and/or laboratory evidence of hepatic, renal, cardiovascular abnormalities
- Esophagitis
- Hiatal hernia
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Iron deficiency (ID) and iron deficiency anemia (IDA) are the most common iron disorders throughout the world.
Read full original descriptionShow less
ID and IDA, particularly caused by increased iron requirements during pregnancy; represent a high risk for preterm delivery, fetal growth retardation, low birth weight, and inferior neonatal health. These pregnancy complications are thought to occur because of an increased iron requirement, related to enhanced blood volume and development of the fetoplacental unit.
The 3 groups in the trial
- Group A: (lactoferrin Group)Existing treatment, for comparison
About 133 anemic pregnant women will be treated with lactoferrin only (pravotin 100mg ) twice daily for 4 weeks.
Treatment: Lactoferrin
- Group B: (Amino acid chelated iron Group)Existing treatment, for comparison
About 133 anemic pregnant women will be treated with amino acid chelated iron only (phara fero 27) once daily for 4 weeks.
Treatment: Lactoferrin
- Group C: (lactoferrin with amino acid chelated iron Group)Existing treatment, for comparison
About 133 anemic pregnant women will be treated with lactoferrin with amino acid chelated iron (phara fero 27 plus ) once daily for 4 weeks
Treatment: Lactoferrin
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Lactoferrin Alone ,Iron Alone Vs Lactoferrin Plus Iron for Treatment of Iron Deficiency Anemia During the 3rd Trimester of Pregnancy (Randomized Controlled Trial)
- Record updated
- 19 September 2024